MentionFox
Home › New brands › HYBRID DRUG
New trademark application · software and business services

Remepy Inc. trademark application for HYBRID DRUG

Before you do business with Remepy Inc.

MentionFox check on Remepy Inc.: only 2 sources on file so far (checked 9 November 2026). Run a full check before you rely on it. mentionfox.com/c/new-brands/hybrid-drug-50155679

Check Remepy Inc. before you do business Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Remepy Inc.?

Filed 2026-10-12, serial number 50155679. Every fact below is from the USPTO record.

Remepy Inc. has applied to register the trademark HYBRID DRUG with the US Patent and Trademark Office for medical and pharmaceutical research and development services (Class 42: software as a service and technology services), and for goods or services in 2 other classes. The filing basis is an intent to use the mark in commerce (USPTO record, serial 50155679, October 12, 2026).

Is this your company?

Free check on Remepy Inc.: what is on record about the company behind this mark →

Remepy Inc., a corporation organized in Delaware, applied to register the trademark HYBRID DRUG with the United States Patent and Trademark Office on 2026-10-12, serial number 50155679. The application covers 3 classes of goods and services, Class 9 (Software and electronics); Class 42 (Software as a service and technology services); Class 44 (Medical and beauty services), and is based on an intent to use the mark in commerce (the goods or services are not yet sold under it). The latest step on the record is "Application filing receipt mailed" on 2026-10-12.

MarkHYBRID DRUG
ApplicantRemepy Inc., a corporation organized in Delaware
Applicant's locationNew York, Delaware
Serial number50155679
Filed2026-10-12
Filing basisAn intent to use the mark in commerce (the goods or services are not yet sold under it)
ClassesClass 9 (Software and electronics); Class 42 (Software as a service and technology services); Class 44 (Medical and beauty services)
Latest step on the recordApplication filing receipt mailed, 2026-10-12

Want the whole picture on Remepy Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Remepy Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Remepy Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

What will HYBRID DRUG be used for?

Class 9 (Software and electronics)

Downloadable computer software and downloadable mobile applications for use in connection with pharmaceutical treatment; Downloadable computer software and downloadable mobile applications for use as digital therapeutics, namely, software for delivering therapeutic interventions for the prevention, management and treatment of diseases and disorders, and alleviating symptoms and improving health conditions associated with diseases and disorders, either as a standalone treatment or in combination with pharmaceutical preparations; Downloadable computer software and downloadable mobile applications featuring video, images, and sound for use in medical-related physical, psychological and cognitive training and for assessing, tracking, and analyzing users' personal health and health-related data; Downloadable computer software and downloadable mobile applications featuring computer games, video, images, and sound intended for improving users' physical and mental condition for medical purposes; Downloadable computer software and downloadable mobile applications incorporating artificial intelligence for physical and mental training for medical purposes; Downloadable computer software and downloadable mobile applications for monitoring and managing patient medical information

Class 42 (Software as a service and technology services)

Medical and pharmaceutical research and development services; Research and development of combination therapies integrating pharmaceutical preparations with digital therapeutics; Providing scientific research information related to medical treatment protocols incorporating digital therapeutics; design and development of computer software for use as digital therapeutics, including digital therapeutics designed for use in combination with pharmaceutical treatment; Providing temporary use of non-downloadable computer software featuring video, images, and sound for use in medical-related physical and mental training, for assessing, tracking, and analyzing users' personal health, and for use as digital therapeutics; Providing temporary use of non-downloadable computer game software for improving users' physical and mental abilities and condition for medical purposes; Providing temporary use of non-downloadable computer software using artificial intelligence for use in physical and mental training for medical purposes; Providing temporary use of non-downloadable computer software for monitoring and managing patient medical information; Providing temporary use of non-downloadable computer software for use as digital therapeutics, namely, software for delivering therapeutic interventions for the prevention, management and treatment of diseases and disorders, and for alleviating symptoms and improving health conditions associated with diseases and disorders, either as a standalone treatment or in combination with pharmaceutical preparations; Providing temporary use of non-downloadable computer software for supporting and complementing pharmaceutical treatment

Class 44 (Medical and beauty services)

Medical services; Medical consulting services, namely, advising and providing information to healthcare professionals and patients regarding medical conditions and treatments; providing medical information in the fields of the prevention, management and treatment of diseases and health conditions; providing medical information related to medical treatment protocols that incorporate the use of digital therapeutics; providing medical information via the internet; providing personal health information via the internet; health counseling services in the fields of disease management and health conditions; health care services, namely, treatment of human diseases and health conditions by using digital therapeutics, alone or in combination with pharmaceutical preparations

Where does the application stand?

DateStep on the record
2026-10-12New application entered
2026-10-12New application office supplied data entered
2026-10-12Application filing receipt mailed

Other new marks from Remepy Inc.

FiledMarkClasses
2026-10-12HYBRID DRUG5
Watching HYBRID DRUG launch?

MentionFox follows a brand's mentions across social platforms, news, forums and reviews. Sign up and HYBRID DRUG is already filled in as the brand to track.

Monitor mentions of HYBRID DRUG
Launching a site for HYBRID DRUG? Add a website chat operator

GetFoxChat puts an AI chat operator on your website that answers visitors from your own pages. Check your site to see what it would answer.

Check your site with GetFoxChat
Selling to Remepy Inc.?

Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.

Order Full Report on Remepy Inc.

Where this comes from

A company that wants to protect a new brand name in the United States files a trademark application with the United States Patent and Trademark Office. The application names the mark, the company applying, the classes of goods and services it will be used for, in the company's own words, and whether the brand is already on sale or is still to launch. Each application gets a serial number and a public record that follows it through examination.

Every fact on this page is taken from that record and linked to it. MentionFox lists applications by companies only, corporations and limited liability companies; applications filed by individuals are not listed. A filing shows a company's plans for a name; it does not show sales, and an application can still be refused or abandoned.

Source: USPTO record for HYBRID DRUG, serial number 50155679.

Cite this page

Permanent URL: https://mentionfox.com/new-brands/hybrid-drug-50155679
Last updated 2026-11-07
Primary record: USPTO trademark record
HYBRID DRUG: new Remepy Inc. trademark filed Oct 12, 2026. MentionFox, 2026-11-07. https://mentionfox.com/new-brands/hybrid-drug-50155679